
Promising Novartis Data at ASCO and EHA Reflects Strong Pipeline and Innovative Portfolio
Novartis is set to unveil data from 60 company- and investigator-sponsored abstracts at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) Congress. These presentations spotlight advances that could reshape clinical practice across…













